Print

LFn-p24 vaccine

Phase I clinical trial to assess the safety and immunogenicity of an HIV vaccine based on AVANT's Therapore(R) technology

Trial Details:

I Completed
Walter Reed Army Institute of Research (WRAIR), , National Institute of Allergy and Infectious Diseases (NIAID) July 01, 2004
LFn-p24 Gag
LFn-p24 Protein
USA 18
http://phx.corporate-ir.net/phoenix.zhtml?c=93243&p=irol-newsArticle&t=Regular&id=526556&